• S&P 500: 1,339.28
  • Change: -0.94%
$3.15 0.03 (+0.96%)
2/10/2012 2:45 PM

Simulations Plus, Inc. (NASDAQ:SLP)

CAPS Rating: 4 out of 5

The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.

Current Price $3.15 Mkt Cap $48.93M
Open $3.15 P/E Ratio 16.80
Prev. Close $3.12 Div. (Yield) N/A (N/A)
Daily Range $3.15 - $3.17 Volume 3,752
52-Wk Range $2.47 - $3.60 Avg. Daily Vol. 0

News & Discussion Boards

Caps

This ticker is not currently Ratable.

All Players

49 Outperform
3 Underperform
 

All-Star Players

11 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top SLP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

billbu (97.53)
Submitted September 11, 2007

SLP's primary business is developing and producing best in class molecular modeling software for pharmaceutical discovery and development. The ability to predict the properties of proposed molecules allows researchers to avoid wasting time and… More

Add Comment | Reply | Report this Post

doublet83 (85.80)
Submitted September 25, 2007

Market overestimating the addressable market of their product. Valuation can only be justified if historical growth rates are sustained for a significant period of time, but these growth rates are clearly unsustainble.

Add Comment | Reply | Report this Post
SLP VS S&P 500 (SPY)

Fools bullish on SLP are also bullish on:

Fools bearish on SLP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SLP.

Recs

0
Member Avatar anguijm (50.96) Submitted: 4/25/2011 7:23:11 AM : Outperform Start Price: $3.21 SLP Score: -2.22

Drugs and making drugs are not going away anytime soon. As health care costs rise one can see this company, which supports drug makers through simulation software, becomes more valuable to someone's bottom line. I doubt they will be bought out but with marketing and their niche feel they have potential to plug along quietly for years to come.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar oohaeagle (< 20) Submitted: 2/7/2011 1:36:04 PM : Outperform Start Price: $3.57 SLP Score: -13.24

I really like the chart for SLP and the other metrics. Good insider ownership. Buying back stock. With drug companies looking to reduce costs anywhere they can, SLP can help. Also a potential buy out candidate as they gain more share and get the attention of others like Charles River, for example.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar HollowMountain (< 20) Submitted: 2/6/2011 10:56:18 AM : Outperform Start Price: $3.44 SLP Score: -10.49

Showing a growing footprint in healthcare, as well as a new deal with the FDA. The fundamentals are solid and the potential is huge.

Report this Post Add Comment | Reply | Permalink
View All 9 Pitches »

Leaderboard

Find the members with the highest scoring picks in SLP.

Score Leader

doublet83

doublet83 (85.80) Score: +55.03

The Score Leader is the player with the highest score across all their picks in SLP.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
doublet83 85.80 9/20/2007 Underperform NS $8.50 -62.94% -8.00% +54.95 1 Comment
jennayyzoh 77.98 9/18/2007 Underperform 5Y $7.47 -57.86% -5.21% +52.65 0 Comment
Stankonia238 36.16 9/6/2007 Underperform 1Y $6.74 -53.30% -4.65% +48.65 0 Comment
Southoftheborder < 20 12/14/2010 Outperform 5Y $2.62 +20.23% +7.85% +12.38 0 Comment
Pepe150 < 20 1/12/2011 Outperform 1Y $2.75 +14.55% +4.63% +9.91 1 Comment
eversuhoshin 64.70 7/9/2010 Outperform 5Y $2.37 +32.91% +25.22% +7.69 0 Comment
stratisticalarb 97.44 5/6/2011 Outperform 1Y $2.94 +7.14% -0.07% +7.22 0 Comment
gopyerk 47.23 5/5/2011 Outperform 1Y $2.98 +5.70% -0.02% +5.73 0 Comment
pureoncharts 28.37 1/18/2011 Outperform 3W $2.93 +7.51% +3.85% +3.66 0 Comment
browns31 < 20 7/14/2010 Outperform 1Y $2.50 +26.00% +22.83% +3.17 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SLP.

Featured Broker Partners